![]() |
市場調查報告書
商品編碼
2008780
雷射捕獲顯微切割市場報告:按產品類型、系統類型、應用、最終用戶和地區分類(2026-2034 年)Laser Capture Microdissection Market Report by Product, System Type, Application, End User (Hospitals, Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations ), and Region 2026-2034 |
||||||
2025年,全球雷射捕獲顯微切割市場規模達1.76億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到3.796億美元,2026年至2034年的複合年成長率(CAGR)為8.50%。個人化醫療需求的不斷成長、癌症研究的拓展、生物標記發現的重大進展以及藥物研發的進步是推動市場成長的主要因素。
癌症發生率上升
隨著癌症和其他慢性疾病發生率的上升,對精準細胞分析的需求日益成長。全球範圍內,癌症病例不斷增加。例如,根據美國癌症協會日誌,預計到2024年,美國將新增200.1萬例癌症病例,並有61.17萬人死於癌症。雷射捕獲顯微切割(LCM)技術被廣泛用於收集和研究癌細胞,尤其是在腫瘤分析、基因突變分析和其他診斷用途方面。這些因素表明,未來幾年雷射捕獲顯微切割的市場佔有率預計將擴大。
不斷發展的生物銀行產業
生物銀行產業的蓬勃發展是市場成長的主要驅動力之一。例如,根據IMARC統計,2023年全球生物銀行市場規模達610億美元。展望未來,IMARC Group預測,到2032年,該市場規模將達到991億美元,2024年至2032年的複合年成長率(CAGR)為5.4%。生物樣本庫儲存大量的生物樣本,研究人員利用這些樣本來闡明疾病機制、發現藥物和識別生物標記。雷射捕獲顯微切割(LCM)在這些樣本的製備過程中至關重要,因為它能夠從異質組織樣本中精確分離特定細胞。這些因素進一步對雷射捕獲顯微切割市場的價格產生了積極影響。
增加研發投入
各國政府、研究機構和私人公司都在大力投資研發,以推動精準醫療和基因組學的發展。例如,2024年9月,專注於醫療保健領域的全球成長型資本公司TVM Capital Healthcare對總部位於舊金山的全球精準醫療和長壽科學公司Human Longevity, Inc. (HLI)進行了大筆股權投資。雷射捕獲顯微切割(LCM)技術在精準醫療領域發揮著至關重要的作用,因為它能夠幫助研究人員分離特定細胞,進行基因分析和疾病機制研究。 LCM的精準性推動了雷射捕獲顯微切割市場的收入成長,因為它有助於制定個人化治療方案,並已成為基因組學研究的關鍵工具。
The global laser capture microdissection market size reached USD 176.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 379.6 Million by 2034, exhibiting a growth rate (CAGR) of 8.50% during 2026-2034. The increasing demand for personalized medicines, expanding cancer research, significant growth in biomarker discovery, and advancements in drug development are primarily propelling the market's growth.
Rising Incidence of Cancer
The rising incidence of cancer and other chronic diseases has increased the need for precise cellular analysis. There has been a significant number of cancer patients across various regions. For instance, according to American Cancer Society Journals, in 2024, the United States is expected to see 2,001,000 new cancer cases and 611,700 cancer deaths. LCM is used extensively to capture and study cancerous cells, especially for tumor profiling, genetic mutations, and other diagnostic purposes. These factors are expected to propel the laser capture microdissection market share in the coming years.
Expanding Biobanking Industry
The growing biobanking industry is one of the key factors driving the market growth. For instance, according to IMARC, the global biobanking market size reached US$ 61.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. Biobanks store vast amounts of biological samples, which researchers use for studying disease mechanisms, drug development, and biomarker discovery. LCM is critical for preparing these samples by enabling the precise isolation of specific cells from heterogeneous tissue samples. These factors further positively influence the laser capture microdissection market price.
Increasing Investment in R&D
Governments, research institutions, and private companies are heavily investing in R&D to advance precision medicine and genomics. For instance, in September 2024, TVM Capital Healthcare, an international growth capital firm focused on healthcare, made a significant equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global precision medicine and longevity science company. LCM technology plays a pivotal role in precision medicine areas, as it enables researchers to isolate specific cells for genetic analysis and study of disease mechanisms. The precision of LCM supports the development of personalized treatment plans, making it a key tool in genomic research, thereby boosting the laser capture microdissection market revenue.
According to the laser capture microdissection market outlook, instruments form the core of LCM technology, including the laser systems, microscopes, and automation tools that enable precise cell and tissue capture. Modern LCM instruments have become more advanced with features like high-resolution imaging, automated sample handling, and integration with other lab equipment. The demand is driven by the need for these sophisticated tools that enhance precision, speed, and efficiency in capturing cells from complex tissues. Moreover, consumables are essential for daily research and experimental activities in genomics, proteomics, and cell biology. The growing number of research projects in universities, research institutions, and biotech companies increases the demand for LCM consumables.
Ultraviolet LCM currently holds the majority of the total market share
According to the laser capture microdissection market overview, UV LCM technology is known for its high precision in cutting and capturing cells with minimal thermal damage to the surrounding tissues. This makes it ideal for applications where maintaining cell integrity is crucial, such as in genetic and molecular analysis. Moreover, neurological disorders like Alzheimer's, Parkinson's, and multiple sclerosis require the analysis of specific neurons and brain tissue regions. UV LCM is widely used in neuroscience research to dissect precise areas of brain tissues, enabling researchers to study disease pathology at the cellular level.
Research and development exhibits clear dominance in the market
LCM technology is highly valued in genomics research for isolating pure cell populations to perform DNA, RNA, and protein analysis. The precision offered by LCM is essential for generating high-quality data in genetic sequencing, transcriptomics, and epigenetic studies, driving its adoption in R&D. Moreover, precision medicine aims to develop tailored treatment strategies based on an individual's genetic makeup and cellular characteristics. LCM supports these efforts by providing specific cell samples that are crucial for understanding patient-specific disease mechanisms and drug response, driving its increased use in R&D.
Academic and government research institutes account for the largest market share
Academic and government research institutes are at the forefront of exploring fundamental biological processes. LCM plays a critical role in isolating specific cells from complex tissues, allowing researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Moreover, cancer research is a major focus in both academic and government research institutions. LCM is a key tool for isolating cancer cells from surrounding tissues to study tumor heterogeneity, gene mutations, and the molecular mechanisms driving cancer progression. As these institutions receive substantial government funding for cancer research, the demand for LCM technology rises.
North America currently dominates the global market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.
According to the laser capture microdissection market statistics, North America, especially the United States, is a global leader in personalized medicine. LCM technology plays a critical role in isolating specific cells from tissues for genomic and molecular analysis, which is essential for tailoring treatment to individual patients. The increasing focus on personalized healthcare is driving the demand for LCM technology in both research and clinical settings. Moreover, LCM is widely used for tumor profiling, identifying cancer biomarkers, and studying tumor microenvironments, which are key to developing personalized cancer treatments. The rising adoption of precision oncology across North America is a significant growth driver for the LCM market.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: